Molecular Pharmacology (USA) Ltd. — key financial figures for fiscal year 2014 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2014)

$2.3K

Net Income/Loss (FY2014)

-$116.9K

Total Equity (FY2014)

-$2.2M

Cash Flows from Operating Activities (FY2014)

-$105.4K

Source: Molecular Pharmacology (USA) Ltd. 10-K filing (FY2014). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.